Skip to main content
SpringerLink
Log in
Book cover

Vitiligo pp 219–230Cite as

In Vitro Approaches

  • Chapter

  • 1702 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Reference

  1. Bell E, Sher S, Hull B et al (1983) The reconstitution of living skin. J Invest Dermatol 81:2s–10s

    Article  PubMed  CAS  Google Scholar 

  2. Bessou S, Surlève-Bazeille JE, Sorbier E, Taïeb A (1995) Ex vivo reconstruction of the epidermis with melanocytes and the influence of UVB. Pigment Cell Res 8:241–249

    Article  PubMed  CAS  Google Scholar 

  3. Black AF, Bouez C, Perrier E et al (2005) Optimization and characterization of an engineered human skin equivalent. Tissue Eng 11:723–733

    Article  PubMed  CAS  Google Scholar 

  4. Boissy RE, Liu YY, Medrano EE et al (1991) Structural aberration of the rough endoplasmic reticulum and melano-some compartmentalization in long-term cultures of melano-cytes from vitiligo patients. J Invest Dermatol 97:395–404

    Article  PubMed  CAS  Google Scholar 

  5. Bondanza S, Maurelli R, Paterna P et al (2007) Keratinocytes cultures from involved skin in vitiligo patients show an impaired in vitro behaviour. Pigment Cell Res 20:288–300

    Article  PubMed  CAS  Google Scholar 

  6. Cario-André M, Bessou S, Gontier E et al (1999) The reconstructed epidermis with melanocytes: a new tool to study pigmentation and photoprotection. Cell Mol Biol 45:931– 942; Review (Erratum in: Cell Mol Biol (2000); 446:489)

    PubMed  Google Scholar 

  7. Cario-André M, Pain C, Gaythier Y et al (2007) The mel-anocythorragic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis. Pigment Cell Res 20:385–393

    PubMed  Google Scholar 

  8. Dell'Anna ML, Maresca V, Briganti S et al (2001) Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo. J Invest Dermatol 117:908–913

    Article  PubMed  Google Scholar 

  9. Dell'Anna ML, Urbanelli S, Mastrofrancesco A et al (2003) Alterations of mitochondria in peripheral blood mononulcear cells of vitiligo patients. Pigment Cell Res 16:553–559

    Article  PubMed  Google Scholar 

  10. Dell'Anna ML, Ottaviani M, Albanesi V et al (2007) Membrane lipid alterations as a possible basis for melano-cyte degeneration in vitiligo. J Invest Dermatol 127:1226–1233

    Article  PubMed  Google Scholar 

  11. Donmez-altuntas H, Sut Z, Ferahbas A et al (2008) Increased micronucleus frequency in phytohaemagglutinin-stimulated blood cells of patients with vitiligo. JEADV 22:162–167

    PubMed  CAS  Google Scholar 

  12. Dykens JA, Fleck B, Ghosh S et al (2002) High-throughput assessment of mitochondrial membrane potential in situ using fluorescence resonance energy transfer. Mitochondrion 1:461–473

    Article  PubMed  CAS  Google Scholar 

  13. Eves PC, Beck AJ, Shard AG et al (2005) A chemically defined surface for the co-culture of melanocytes and kerati-nocytes. Biomaterials 26:7068–7081

    Article  PubMed  CAS  Google Scholar 

  14. Giovannelli L, Bellandi S, Pitozzi V et al (2004) Increased oxidative DNA damage in mononuclear leukocytes in viti-ligo. Mut Res 556:101–106

    Article  CAS  Google Scholar 

  15. Goding CR (2007) Melanocytes: the new black. Pigment Cell Res 39:275–279

    CAS  Google Scholar 

  16. Graham A, Westerhof W, Thody AJ (1999) The expression of a-MSH by melanocytes is reduced in vitiligo. Ann NY Acad Sci 885:470–473

    Article  PubMed  CAS  Google Scholar 

  17. Halaban R, Alfano FD (1984) Selective elimination of fibro-blasts from cultures of normal human melanocytes. In vitro 20:447–450

    Article  PubMed  CAS  Google Scholar 

  18. Han X (2007) Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer's disease: a tale of shotgun lipidomics. J Neurochem 103:171–179

    Article  PubMed  CAS  Google Scholar 

  19. Ivanova K, van der Wijngaard R, Gerzer R et al (2005) Non-lesional vitiliginous melanocytes are not characterized by an increased proness to nitric oxide-induced apoptosis. Exp Dermatol 14:445–453

    Article  PubMed  CAS  Google Scholar 

  20. Jimbow K, Chen H, Park JS et al (2001) Increased sensitivity of melanocytes to oxidative stress an dabnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol 144:55–65.

    Article  PubMed  CAS  Google Scholar 

  21. Kauser S, Thody AJ, Schallreuter KU et al (2004) β-Endorphin as a regulator of human hair follicle melano-cyte biology. J Invest Dermatol 123:184–195

    Article  PubMed  CAS  Google Scholar 

  22. Kawase A, Kushimoto T, Kawa Y et al (2008) Proteomic analysis of immature murine melanocytes at different stages of maturation: a crucial role for calreticulin. J Dermatol Sci 49:43–52

    Article  PubMed  CAS  Google Scholar 

  23. Kitamura R, Tsukamoto K, Harada K et al (2004) Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M. J Pathol 202:463–475

    Article  PubMed  CAS  Google Scholar 

  24. Kroll TM, Bommiasamy H, Boissy RE et al (2005) 4-tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo. J Invest Dermatol 124:798–806

    Article  PubMed  CAS  Google Scholar 

  25. Lee AY, Kim NH, Choi WI et al (2005) Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo. J Invest Dermatol 124:976–983

    Article  PubMed  CAS  Google Scholar 

  26. Lee DY, Lee JH, Yang JM et al (2006) A new dermal equivalent: the use of dermal fibroblast culture alone without exogenous materials. J Dermatol Sci 43:95–104

    Article  PubMed  CAS  Google Scholar 

  27. Le Poole IC, Stennett LS, Bonish BK et al (2003) Expansion of vitiligo lesions is associated with reduced epidermal Cdw60 expression and increased expression of HLA-DR in perilesional skin. Br J Dermatol 149:739–748

    Article  PubMed  Google Scholar 

  28. Maresca V, Roccella M, Roccella F et al (1997) Increased sensitivity to peroxidative agents as a possible pathogenetic factor of melanocyte damage in vitiligo. J Invest Dermatol 109:310–313

    Article  PubMed  CAS  Google Scholar 

  29. Medrano EE, Nordlund JJ (1990) Successful culture of adult human melanocytes obtained from normal and vitiligo donors. J Invest Dermatol 95:441–445

    PubMed  CAS  Google Scholar 

  30. Na GY, Paek SH, Park BC et al (2006) Isolation and characterization of outer root sheath melanocytes of human hair follicles. Br J Dermatol 155:902–909

    Article  PubMed  CAS  Google Scholar 

  31. Norris A, Todd C, Graham A et al (1996) The expression of the c-kit receptor by epidermal melanocytes maybe reduced in vitiligo. Br J Dermatol 134:299–306

    Article  PubMed  CAS  Google Scholar 

  32. Ouvry-Patat SA, Torres MP, Quek HH et al (2008) Free-flow electrophoresis for top-down proteomics by Fourier transform ion cycloton resonance mass spectrometry. Proteomics 8:2798–2808

    Article  PubMed  CAS  Google Scholar 

  33. Palermo B, Campanelli R, Garbelli S et al (2001) Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histo-compatibility complex/peptide tetramers: the role of cellular immunity in the aetiopathogenesis of vitiligo. J Invest Dermatol 117:326–332

    Article  PubMed  CAS  Google Scholar 

  34. Poumay Y, Coquette A (2007) Modelling the human epidermis in vitro: tools for the basic and applied research. Arch Dermatol Res 298:361–369

    Article  PubMed  Google Scholar 

  35. Prunieras M, Regnier M, Schlotterer M (1979) [New procedure for culturing human epidermal cells on allogenic or xenogenic skin: preparation of recombined grafts]. Ann Chir Plast 24:357–362

    PubMed  CAS  Google Scholar 

  36. Richmond B, Huizing M, Knapp J et al (2005) Melanocytes derived from patients with Hermansky-Pudlak syndrome types 1, 2 and 3 have distinct defects in cargo trafficking. J Invest Dermatol 124:420–427

    Article  PubMed  CAS  Google Scholar 

  37. Régnier M, Staquet MJ, Schmitt D et al (1997) Integration of Langerhans cells into a pigmented reconstructed human epidermis. J Invest Dermatol 109:510–512

    Article  PubMed  Google Scholar 

  38. Rosdy M, Bjorklund MG, Asplud A et al (1990) Terminal epidermal differentiation of human keratinocytes grown in chemically defined medium on inert filter substrates at the hair-liquid interface. J Invest Dermatol 95:409–414

    Article  PubMed  CAS  Google Scholar 

  39. Stromberg S, Bjorklund MG, Asplud A et al (2008) Transcriptional profiling of melanocytes from patients with vitiligo vulgaris. Pigment Cell Melanoma Res 21:162–171

    Article  PubMed  Google Scholar 

  40. Tellez CS, Davis DW, Prieto VG et al (2007) Quantitative analysis of melanocytic tissue array reveals inverse correlation between activator protein-2 alpha and protease-activated receptor-1 expression during melanoma progression. J Invest Dermatol 127:387–393

    Article  PubMed  CAS  Google Scholar 

  41. Tobin DJ, Colen SR, Bystryn JC (1995) Isolation and longterm culture of human hair-follicle melanocytes. J Invest Dermatol 104:86–89

    Article  PubMed  CAS  Google Scholar 

  42. Van den Wijngaard RMJGJ, Aten J, Scheepmaker A et al (2000) Expression and modulation of apoptosis regulatory molecules in human melanocytes: significance in vitiligo. Br J Dermatol 143:573–581

    Article  PubMed  Google Scholar 

  43. Vennegor C, Hageman P, Van Nouhuijs H et al (1988) A monoclonal antibody specific for cells of the melanocyte lineage. Am J Pathol 130:179–192

    Google Scholar 

  44. Yang F, Boissy RE (1999) Effects of 4-tertiary butylphenol on the tyrosinase activity in human melanocytes. Pigment Cell Res 12:237–245

    Article  PubMed  CAS  Google Scholar 

  45. Yang F, Sarangarajan R, Le Poole IC et al (2000) The cyto-toxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity. J Invest Dermatol 114:157–164

    Article  PubMed  CAS  Google Scholar 

  46. Zhang RZ, Zhu WY, Xia MY et al (2004) Morphology of cultured human epidermal melanocytes observed by atomic force microscopy. Pigment Cell Res 17:62–65

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre de référence des maladies rares de la peau, Université V Segalen Bordeaux 2, Inserì U876, Bordeaux, France

    Muriel Cario-André

Authors
  1. Muriel Cario-André
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Lucia Dell'Anna
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Muriel Cario-André .

Editor information

Editors and Affiliations

  1. Istituto Dermatologico San Gallicano, via Elio Chianesi 53, Roma, 00144, Italy

    Mauro Picardo

  2. Service de Dermatologie De Dermatologie Pédiatrique, Centre de référence des maladies rares de la Peau Hôpital Saint-André, 1 rue Jean Burguet, Bordeaux, 33000, France

    Alain Taïeb

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Cario-André, M., Dell'Anna, M.L. (2010). In Vitro Approaches. In: Picardo, M., Taïeb, A. (eds) Vitiligo. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69361-1_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69361-1_26

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69360-4

  • Online ISBN: 978-3-540-69361-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation